By Charles Toutant | April 6, 2018
In the nation's first trial where a jury linked Johnson & Johnson's talc products to mesothelioma, the company's efforts to discredit the plaintiffs' evidence simply fell flat.
By Kristen Rasmussen | March 21, 2018
A partner in Covington & Burling's food, drug, and device practice group and a former associate chief counsel for enforcement in the U.S. Food and Drug Administration's Office of Chief Counsel is named GC at the pharmaceutical giant.
By Michael Booth | March 19, 2018
The three-judge Appellate Division panel reinstated the lawsuit, which alleged that 42-year-old Michelle Skounakis died 15 days after she was prescribed Cytomel, a thyroid hormone that can be used as a weight-loss medication.
By Amanda Bronstad | March 7, 2018
U.S. District Judge Dan Polster in Cleveland told lawyers in the multidistrict litigation to come up with a plan by March 16 over the scope and timing of a “litigation track.”
By Max Mitchell | February 27, 2018
Sessions outlined plans to create a new litigation-oriented task force within the Department of Justice to pursue claims against opioid manufacturers and distributors.
By Michael Booth | February 22, 2018
New Jersey Attorney General Gurbil Grewal on Thursday announced an expansion of the state's efforts to combat the ongoing opioid addiction crisis.
Delaware Business Court Insider | News
By Tom McParland | February 20, 2018
A Delaware federal judge on Feb. 16 overturned a massive $2.5 billion jury verdict against Gilead Sciences Inc., finding that a patent held by a unit of Merck & Co. Inc. was too broad to be valid.
By Charles Toutant | February 9, 2018
The company artificially inflated its stock price by failing to disclose what it knew about links between cancer and Johnson's Baby Powder, according to the suit.
By Scott Graham | February 6, 2018
In an appellate showdown between Fish & Richardson's Juanita Brooks and MoloLamken's Jeffrey Lamken, a Federal Circuit panel seemed swayed by Merck's argument that one bad witness didn't taint the jury's verdict.
By Michael Booth | January 30, 2018
A New Jersey appeals court handed Swiss pharmaceutical giant Hoffmann-La Roche a minor victory when it affirmed a trial judge's ruling that four plaintiffs in the Accutane litigation blew the statute of limitations in filing their product liability lawsuits.
Presented by BigVoodoo
New Jersey Law Journal honors lawyers leaving a mark on the legal community in New Jersey with their dedication to the profession.
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
The Daily Report is honoring those attorneys and judges who have made a remarkable difference in the legal profession.
Company Description CourtLaw Injury Lawyers is an established Personal Injury Law Firm with its primary office located in Perth Amboy, New J...
Black Owl Recruiting is looking for a number of qualified applicants to fill positions for a highly reputable client. Recent experience work...
McManimon, Scotland & Baumann, LLC is seeking talented and motivated Associate Attorneys with 3-7 years of experience working closely wi...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS